Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Host Response and Inflammation

Immunohistochemical Analysis of Lyme Disease in the Skin of Naive and Infection-Immune Rabbits following Challenge

Celeste Chong-Cerrillo, Ellen S. Shang, David R. Blanco, Michael A. Lovett, James N. Miller
Celeste Chong-Cerrillo
Department of Microbiology and Immunology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ellen S. Shang
Department of Microbiology and Immunology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David R. Blanco
Department of Microbiology and Immunology, and
Division of Infectious Disease, Department of Medicine, University of California, School of Medicine, Los Angeles, California 90095
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Lovett
Department of Microbiology and Immunology, and
Division of Infectious Disease, Department of Medicine, University of California, School of Medicine, Los Angeles, California 90095
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James N. Miller
Department of Microbiology and Immunology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.69.6.4094-4102.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

In this study, skin histopathology from naive and infection-derived immune rabbits was compared following intradermal challenge usingBorrelia burgdorferi B31 strain. The presence or absence of spirochetes in relationship to host cellular immune responses was determined from the time of intradermal inoculation to the time of erythema migrans (EM) development (∼7 days in naive rabbits) and through development of challenge immunity (∼5 months in naive rabbits). Skin biopsies were obtained and analyzed for the presence of spirochetes, B cells, T cells, polymorphonuclear cells (PMNs), and macrophages by immunohistochemical techniques. In infected naive animals, morphologically identifiable spirochetes were detected at 2 h and up to 3 weeks postinfection. At 12 and 24 h postinfection there was a marked PMN response that decreased by 36 to 48 h; by 72 h the PMNs were replaced by a few infiltrating macrophages. At the time of EM development and 14 days postinfection, the PMNs and macrophages were replaced by a lymphocytic infiltrate. There was a greater number of spirochetes at 14 days, a time when EM had resolved, than at 7 days postinfection. By 3 weeks postinfection there were few organisms and lymphocytes detectable. In contrast to infected naive rabbits, intact spirochetes were never visualized in skin biopsies from infection-immune rabbits; only spirochetal antigen was detected at 2, 12, and 24 h in the presence of a numerous PMN infiltrate. By 36 h postchallenge, spirochetal antigen could not be detected and the PMN response was replaced by a few infiltrating macrophages. By 72 h postchallenge, PMNs and macrophages were absent from the skin; B and T cells were never detected at any time point in skin from infection-immune rabbits. The destruction of spirochetes in immune animals in the presence of PMNs and in the absence of a lymphocytic infiltrate suggests that infection-derived immunity is antibody mediated.

Lyme disease is the most common vector-borne disease in the United States (28). The disease is transmitted to humans by the bite of an infectedIxodes tick harboring either Borrelia burgdorferisensu stricto, B. afzelii, or B. garinii, related spirochetes collectively termed B. burgdorferi sensu lato. In the majority of patients, Lyme disease is characterized by the initial appearance of a rash-like skin lesion termed erythema migrans (EM) (39, 42). Early and late clinical manifestations include arthritis, neurological manifestations, lymphadenopathy, and carditis, which reflects dissemination to visceral targets (1, 16, 24, 29, 30, 34, 38, 40-43). Although Lyme disease is rarely fatal, it can be quite debilitating.

Implicit in the development of an effective vaccine against Lyme disease is a thorough understanding of the pathogenetic mechanisms as well as the host immune response operative during host-spirochete interaction. In the murine model of Lyme disease, the histopathology is characterized by a lymphocytic and plasma cell infiltration, occasional perivascular cuffing, and few or no detectable macrophages (8, 13, 18, 27, 32, 37). BALB/c and C3H mice have been used in elucidating the immune response of the host following infection with B. burgdorferi. Humoral immunity has been shown to play a major role in resistance to Lyme disease, although cellular immunity has also been demonstrated to influence the outcome of arthritis severity and infection (4-6, 20-23, 25, 26, 33, 47, 48). However, a direct relationship between the spirochetes and host immune cells has not been demonstrated. In addition, the chronic nature of the disease in the murine model precludes determining the immune mechanisms involved in clearance of organisms and resolution of the disease.

The rabbit model of Lyme disease has unique features relevant to the immunobiology of B. burgdorferi infection. It is the only animal model besides the rhesus monkey (31) that reproducibly results in EM that is indistinguishable from that of human disease after intradermal inoculation of B. burgdorferi sensu stricto (15). Most importantly, untreated skin and visceral infection is ultimately cleared, resulting in complete immunity against reinfection with up to 2 × 107 challenge organisms (15). Thus, in the rabbit model of Lyme disease, it is possible to examine the effective host immune factors, humoral and cellular, associated with acquired resistance against infection with B. burgdorferi.

In the current study, we directed our efforts toward elucidating the outcome of host-spirochete interaction following the intradermal inoculation of naive and infection-derived immune rabbits withB. burgdorferi B31 from the time of intradermal inoculation to the time of EM development and through development of challenge immunity. We specifically addressed the location and persistence of spirochetes in relationship to the presence and distribution of polymorphonuclear cells (PMNs), macrophages, T cells, and B cells in an effort to determine the potential cellular mechanisms responsible for pathogenesis and host immunity.

MATERIALS AND METHODS

Animals.Adult, male, New Zealand White rabbits 6 to 9 months of age (Irish Farms, Norco, Calif.) were housed individually in a temperature-controlled environment ranging from 18 to 21°C. Prior to intradermal (i.d.) inoculation with B. burgdorferi, the backs of the rabbits were clipped closely with an electric clipper fitted with a size 40 blade to expose the skin (Oster Professional Products, McMinnville, Tenn.).

Male C3H/HeJ mice 6 weeks of age were purchased from Jackson Laboratories (Bar Harbor, Maine) and housed in cages containing no more than five animals.

Bacterial strains and preparation of inocula for infection and challenge.Virulent B. burgdorferi sensu stricto, strain B31, was isolated from infected rabbit tissue, grown in BSK II medium (7) to maximum density, and then passaged twice more in fresh BSK II medium. After the final passage (passaged two times), the organisms were centrifuged gently at 8,000 × g for 10 min and washed three times in heat-inactivated (56°C for 30 min) normal rabbit serum (NRS), diluted 1:1 with phosphate-buffered saline (PBS; pH 7.2) (NRS-PBS), in order to remove foreign protein components responsible for nonspecific reactions in the rabbit (15, 36). Inocula for infection and challenge were resuspended in NRS-PBS after the final wash to a final concentration containing 107 or 108B. burgdorferi per ml depending on the experiment. As in previously published experiments (15, 36), the spirochetes in the final suspension were motile and virulent.

Generation and challenge of infection-derived immune rabbits.Based on previous studies in which a high degree of infection-derived immunity to challenge was established (15), rabbits were infected i.d. with doses ranging from 6 × 106 to 8 × 107B. burgdorferi depending on the experiment. Inocula were administered in 0.1-ml doses at several sites. Six months after infection, at a time when EM lesions had healed, dermal infection was absent and, on the basis of our previously described studies, visceral dissemination was no longer demonstrable (15), the rabbits were challenged i.d. with doses ranging from 107 to 108B. burgdorferi depending on the experiment. In addition, naive rabbits were inoculated in the same manner to serve as controls.

Skin biopsy and culture.Skin punch biopsies were obtained from all experimental and control rabbits at various time points postinfection (p.i.) and postchallenge (p.c.). Rabbits were anesthetized by intramuscular injection with 45 mg of Ketaset (Fort Dodge Laboratories, Fort Dodge, Iowa) and 8.8 mg of Xylazine (Lloyd Laboratories, Shenandoah, Iowa) per kg of body weight. A 4- to 5-mm sterile punch biopsy (Baker and Cummings, Lakewood, N.J.) was taken adjacent to the inoculation site from the clipped back of each rabbit. Each biopsy specimen was immediately minced and cultured in 5 ml of BSK II medium containing 100 μg of phosphomycin per ml and 50 μg of rifampin per ml (Sigma, St. Louis, Mo.).

Cultures were incubated aerobically at 34°C for a period of 7 weeks, and the presence or absence of B. burgdorferi was determined periodically by dark-field microscopy. Cultures were considered negative when no sprochetes were observed during the 7-week observation period.

Preparation of polyclonal mouse anti-B. burgdorferiimmunoglobulin G (IgG) for immunohistochemical detection of B. burgdorferi in skin sections.Virulent B. burgdorferi was grown as described above to passage 3. Organisms were washed three times by suspension in PBS followed by centrifugation at 8,000 × g for 10 min. After the final wash, organisms were resuspended in PBS to a final volume containing 1010B. burgdorferi per ml. The organisms were then disrupted by ultrasonic treatment and stored at −80°C until ready for use.

Twenty C3H/HeJ mice were hyperimmunized with the above-prepared suspensions of B. burgdorferi. For the initial immunization, an equal volume of organisms (ca. 100 μl) was mixed 1:1 with complete Freund adjuvant (Calbiochem Corp., La Jolla, Calif.) and administered subcutaneously (s.c.). Two booster immunizations at 4-week intervals were also given s.c. using 100 μl of the B. burgdorferisuspension mixed 1:1 with incomplete Freund adjuvant (Calbiochem Corp.). Four weeks after the final boost immunization, all mice were euthanized and blood obtained by cardiac puncture. The sera were then pooled and the IgG fraction was isolated by fast-performance liquid chromatography using a protein A-Superose column (HR 10/2; Pharmacia Biotech, Uppsala, Sweden). As determined by enzyme-linked immunosorbent assay, the isolated IgG fraction was found to have an anti-B. burgdorferi titer of 1:16,000 and was reactive to all Amido black-stained B. burgdorferi antigens as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by immunoblot analysis (data not shown).

Immunohistochemical staining of skin biopsies.Skin punch biopsies of 4 to 5 mm were obtained from all experimental and control rabbits at various time points p.i. and p.c. The punch biopsies were embedded in O.C.T. compound (Sakura Finetek, U.S.A., Inc., Torrance, Calif.) and quick-frozen in a dry-ice–2-methylbutane bath. Skin punch biopsies from naive rabbits were also obtained and frozen in O.C.T. compound to serve as negative controls for immunohistochemical staining. Frozen O.C.T.-embedded skin specimens were kept at −80°C until ready for use.

Frozen test and control skin biopsy specimens were cut into 4-μm-thick serial sections in a cryostat, collected on Superfrost Plus glass slides (Fisher Scientific, Pittsburgh, Penn.), and fixed with cold acetone for 20 min. Sections were allowed to air dry then incubated in Tris-buffered saline (TBS) for 5 min. Endogenous peroxidase activity was blocked by incubation with 3% H2O2 for 5 min at room temperature. Sections were rinsed well with double-distilled water (ddH2O) followed by incubation in TBS for 5 min. Sections were then blocked with Blotto (5% nonfat dry milk, 1% normal horse serum, and 0.2% sodium azide in TBS) at room temperature for 30 min. After the blocking step, five serial sections were incubated at 4°C overnight with primary antibodies as follows. For the detection of B. burgdorferi, sections were incubated with a 1:5,000 dilution in Blotto of polyclonal mouse anti-B. burgdorferi IgG; for the detection of B cells, T cells, and PMNs or macrophages, sections were incubated with a 1:50 dilution in Reagent Diluent (0.5% bovine serum albumin in TBS) of purified mouse anti-rabbit CD79a monoclonal antibody (MAb), purified mouse anti-rabbit CD3 MAb, or purified mouse anti-rabbit CD11b MAb (Spring Valley Laboratories, Inc., Woodbine, Md.), respectively. After three washes of 5 min each with PBS containing 0.02% Tween 20 (PBS-Tween), the sections were incubated with horse anti-mouse IgG conjugated to biotin (Vector Laboratories, Burlingame, Calif.) diluted 1:200 in PBS-Tween containing 1.5% NHS at 37°C for 30 min. Sections were then washed three times with PBS-Tween followed by incubation with streptavidin peroxidase (Vector ABC Elite kit; Vector Laboratories) at 37°C for 30 min. Sections were washed once with PBS-Tween and then twice with ddH2O, and the color was developed with 3-amino-9-ethyl-carbazole (AEC Chromogen Kit; Biomeda Corp., Foster City, Calif.) at 37°C for 10 min. The reaction was stopped by washing sections in ddH2O, and then the sections were counterstained with a 1- to 2-min incubation in aqueous hematoxylin (Biomeda Corp.). After a counter staining, the sections were rinsed well in running tap water and then mounted with Crystal/Mount (Biomeda Corp.), followed by the addition of a coverslip.

Frozen serial sections of each skin biopsy specimen were also stained with hematoxylin and eosin (H&E) for histopathological examination.

RESULTS

Detection of B. burgdorferi and characterization of the cellular infiltrate during EM in the skin of naive rabbits following infection.To identify and characterize the cellular immune response in the development and resolution of EM, rabbits were infected i.d. with 107B. burgdorferi, and representative skin biopsies were obtained at the time of EM development (day 7 p.i) and EM resolution (day 14 p.i.). Frozen serial sections of skin biopsies were analyzed for the presence of B. burgdorferi, B cell, T cells, and CD11b+ PMNs or macrophages by immunohistochemical staining. In addition, skin biopsy samples were analyzed for the presence ofB. burgdorferi by culture in BSK II medium. As presented in Table 1, all rabbits developed culture-positive EM lesions at day 7 p.i. At day 14 p.i., EM lesions had resolved, but all animals remained skin culture positive. Histological examination showed the presence of intact spirochetes at day 7 which increased in relative numbers by day 14 p.i. (Fig. 1). At the time of the appearance of EM lesions that contained intact spirochetes (day 7 p.i.), there was predominantly a lymphocytic B-cell infiltration with fewer T cells (Fig. 2). By comparison, CD11b+ cells representing PMNs were only occasionally detected in these sections (Table 1). The type and relative quantity of the cellular infiltrate did not differ at day 14 (data not shown) from that of day 7 even though the number of B. burgdorferiwas greater at day 14.

View this table:
  • View inline
  • View popup
Table 1.

Histopathology in B. burgdorferi-infected rabbit skin during development and resolution of EM lesions

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Immunohistochemical staining for the detection ofB. burgdorferi in skin biopsies from infected naive rabbits at the time of EM development (7 days p.i.) (a) and at the time of EM resolution (14 days p.i.) (b). Magnification, ×78.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Immunohistochemical staining of skin biopsies from infected naive rabbits at the time of EM development (7 days p.i.). Serial skin sections were stained for B. burgdorferi(a), B-cell lymphocytes (b), and T-cell lymphocytes (c). Magnification, ×125.

Skin histopathology in rabbits during initial infection and through the development of immunity.Based on previous studies, rabbits infected i.d. 5 months earlier with B. burgdoreri B31 develop complete immunity to challenge reinfection (15). To investigate the role of cellular immunity in the progression and resolution of disease, rabbits were infected i.d. with 6 × 106 to 9 × 106B. burgdorferi, and representative skin biopsies were obtained at 3 and 13 weeks p.i. and again at 24 weeks p.i. when immunity was established. Frozen serial sections of skin biopsies were analyzed by immunohistochemical staining, as described above, and skin biopsy samples were cultured in BSK II medium for detection of viableB. burgdorferi. At 3 weeks p.i., as shown in Table2, 80% of rabbits had culture-positive skin. Immunohistochemical detection showed that, compared to day 14 p.i. (Table 1), the quantity of spirochetes, B cells, and T cells had decreased. By 13 weeks p.i. as well as by 24 weeks p.i., spirochetes were no longer histochemically detectable nor could they be cultured from the skin (Table 2). In addition, lymphocytes were also not detected from skin sections; only rarely were macrophages detected at week 13 p.i. These data are consistent with our previous observations demonstrating that by 5 to 6 months p.i., skin and visceral infection in untreated rabbits is cleared (15).

View this table:
  • View inline
  • View popup
Table 2.

Histopathology in B. burgdorferi-infected rabbit skin during disease progession and development of immunity

Comparative histopathology in the skin immediately following challenge of naive and infection-immune rabbits.To examine early cell mediated immune events following challenge of immune animals, infection-derived immune rabbits previously infected with 8 × 107B. burgdorferi were challenged i.d. with 8 × 107 organisms, and representative skin biopsies were obtained at 2, 12, 24, 36, 48, 72, and 96 h p.c. To compare these early events to those which occur in the nonimmune animal and to more thoroughly investigate immune mechanisms immediately following infection, naive rabbits were inoculated in the same manner, and representative skin biopsies obtained at the same time points as above. Serial sections of skin biopsies were analyzed by immunohistochemical staining and for the presence of viableB. burgdorferi by culture in BSK II medium as before.

In naive animals, B. burgdorferi could be cultured from skin and detected by immunohistochemical staining at each time point p.i. The detection of morphologically intact spirochetes in the skin by immunohistochemical staining at the 36 h p.i. time point, as shown in Fig. 3c and d, was typical of all time points in infected naive rabbits. At 12 and 24 h p.i. there was a marked PMN response which decreased slightly by 36 to 48 h p.i. (Table 3 and Fig. 3e and f). By 72 and 96 h the PMNs were replaced by a few infiltrating macrophages. Overall, there was a mild inflammatory response at these time points. No lymphocytes were evident at any of the above time points (data not shown); however, as mentioned earlier, the appearance of lymphocytes did occur at the time of EM development (day 7 p.i.).

Fig. 3.
  • Open in new tab
  • Download powerpoint
Fig. 3.

Immunohistochemical staining of skin biopsies from infected naive rabbits 36 h p.i. Serial skin sections were stained by H & E (a and b), for B. burgdorferi (c and d), and for the CD11b PMN/macrophage marker (e and f). Magnification is at ×31 (a, c, and e) and ×125 (b, d, and f) from an outlined area of panels a, c, and e, respectively.

View this table:
  • View inline
  • View popup
Table 3.

Histopathology in B. burgdorferi-infected rabbit skin following i.d. infection of naive rabbits

By comparison to the naive animals, skin biopsies from infection-derived immune rabbits were culture positive only up to 36 h p.c. (Table 4), while at 48 h dermal infection was not detected in the skin biopsies examined. Immunohistochemical analysis showed that while B. burgdorferi antigen could be detected at 2, 12, and 24 h p.c. (Table 4 and Fig. 4c and d), morphologically intact spirochetes were never observed in these biopsy sections compared to the infected naive animals (compare Fig. 4d with Fig. 3d). In addition, there was a marked PMN response at 12 and 24 h p.c. in immune animals similar to that observed in the infected naive rabbits (Table 4 and Fig. 4e and f); the PMNs were replaced by a sparse infiltrate of macrophages at 36 and 48 h p.c. (data not shown). By 72 h p.c. no inflammatory cells could be detected in the skin (data not shown). In addition, no lymphocytes were detected at any of the above time points in the challenged infection-immune animals. Further, skin biopsies obtained from 15 additional infection-immune rabbits at weeks 1 and 2 weeks p.c. were, as expected, culture negative (data not shown). Immunohistochemical staining of these 1-week p.c. sections showed no intact spirochetes, only sparse detectable B. burgdorferi antigen and sparse detectable PMNs (data not shown).

View this table:
  • View inline
  • View popup
Table 4.

Histopathology in rabbit skin following i.d. challenge of infection-immune rabbits with B. burgdorferi

Fig. 4.
  • Open in new tab
  • Download powerpoint
Fig. 4.

Immunohistochemical staining of skin biopsies from infection-immune rabbits 24 h after i.d. challenge with B. burgdorferi. Serial skin sections were stained by H & E (a and b), for B. burgdorferi (c and d), and for the CD11b PMN/macrophage marker (e and f). Magnification is at ×31 (a, c, and e) and ×125 (b, d, and f) from an outlined area of a, c, and e, respectively. Note that similar results were obtained from serial skin sections of biopsies taken at 2 and 12 h p.c. (data not shown).

DISCUSSION

In this study we compared the cellular events, including the morphological detection of spirochetes, in the skin of naive and infection-derived immune rabbits following i.d. challenge withB. burgdorferi B31. The observations made encompass the time from inoculation to the development of EM and through the development of challenge immunity. In the early events following the infection of naive animals, morphologically identifiable spirochetes were readily detected at 2 h and through 3 weeks p.i., which paralleled the demonstration of culture-positive skin infection during this time. We have recently reported, using quantitative PCR, that over 108 borreliae are present per cm2 of EM biopsied skin (36), which indicates that the rabbit is a very permissive host during the early course of infection. At 13 weeks p.i., however, skin cultures were consistently negative and no intact spirochetes could be detected by immunohistochemical staining. By comparison, skin samples from infection-immune animals following challenge never showed intact spirochetes; only B. burgdorferi antigen was detected at 2, 12, and 24 h p.c., which could no longer be detected at 36 h. In addition, culture-positive samples were no longer demonstrable from these immune rabbits after the 36-h time point. These findings demonstrate that the infection-derived immunity that develops in experimental rabbit Lyme disease rapidly destroys spirochetes at the site of challenge, as evidenced by the loss of spirochetal morphology and viability.

In order to determine whether specific cell-mediated immune mechanisms contribute to the immunity against challenge that develops in rabbits, immunohistochemical analysis to identify infiltrating PMNs, macrophages, T cells, and B cells was performed. In parallel, the same analysis of naive rabbits following challenge was performed for comparison to that of the immune animals and to characterize the cellular response that occurs from the start of infection to the development of immunity. It was observed that immediately following challenge of either naive or infection-immune rabbits an influx of PMNs occurred and were most prominently present at 12 and 24 h. This PMN infiltration was subsequently replaced by only a sparse infiltrate of macrophages, which in the naive animals persisted for up to 13 weeks p.i. In immune animals, the macrophages were absent by 72 h, a finding concordant with the disappearance of spirochetal antigen. T and B lymphocytes were detected during the time when EM lesions appeared in infected naive animals (day 7 p.i.) but also following the time that EM lesions had resolved (day 14 p.i.). After 13 weeks p.i., T and B lymphoctytes were no longer detectable. By comparison, T and B lymphocytes were never detected in the skin of challenged infection-immune challenged animals. Taken together, these findings show that in naive animals, the resolution of local skin infection correlates with the infiltration of T and B lymphocytes as well as macrophages, suggesting a primary role for cell-mediated immune mechanisms at the time of borrelial clearance. The early inflammatory response of PMNs and macrophages does not appear to affect the initial establishment and persistence of spirochetal infection. By comparison, no correlation was seen between the disappearance of viable spirochetes and a cellular infiltrate of any particular immune cell type in the immune rabbits following challenge, suggesting that humoral immunity plays the primary role in the persistence of acquired resistance. This is consistent with our recent study showing that passive immunization with serum from infection-immune rabbits can completely protect naive rabbits against challenge with large numbers of virulent B. burgdorferi (12). Thus, both cell-mediated and humoral immune mechanisms would appear to be important in the development and persistence of acquired resistance that results during the course of experimental rabbit Lyme disease.

In contrast to the rabbit model of Lyme disease, where infected animals ultimately clear the infection and develop immunity to challenge reinfection, infection in mice and humans is chronic. Thus, a comparison of the immune response that occurs following infection in mice with those in rabbits may provide insights into potential differences that account for the development of immunity versus that of chronic infection. In the mouse model, the host-immune response toB. burgdorferi infection has been studied primarily in BALB/c and C3H strains, the latter noted to be more permissive toB. burgdorferi infection. The humoral arm of the murine immune response has been thought to play a major role in the relative resistance of strains to Lyme disease while the cellular arm has been demonstrated to influence the outcome of disease, including the severity of arthritis (23). Following infection, BALB/c mice, the strain relatively more resistant to Lyme disease infection, are known to express an early predominant Th2 response (humoral immunity), whereas the more susceptible C3H mouse strain has an early predominant Th1 response (cell-mediated immunity) (20, 21, 22). B. burgdorferi-infected C3H mice, compared to infected BALB/c mice, harbor an increased spirochete burden in their joints and concomitantly show a more severe level of arthritis. It has been suggested that differential cytokine production may contribute to the mouse strain-related differences in susceptibility to Lyme disease (22). In this regard, it has been shown that the ablation of the endogenous cytokine interleukin-12 (IL-12), which helps to promote the development of a Th1 response, results in a reduced level of arthritis. Conversely, the ablation of endogenous IL-6, which helps to promote the Th2 response, results in an increased level of arthritis (4). These findings suggest that, in the murine model, humoral mechanisms are primarily responsible for the relative resistance to infection, while a predominant cell-mediated immune response is associated with increased disease severity. In contrast to these studies, Zeidner and colleagues (47) have shown that when susceptible mice are infected via the natural tick vector (Ixodes scapularis), exogenously administered Th1 cytokines reduce the severity of infection. Thus, the difference between chronic infection in mice and complete immunity in rabbits may lie with differences in the specific B. burgdorferi molecules recognized by the humoral and cell-mediated arms of immune response during infection.

We have recently shown that immune rabbits, but not rabbits hyperimmunized with purified outer membrane from in vitro-cultivated borreliae, are completely protected following challenge using organisms acquired from infected rabbit skin (36). We demonstrated that these organisms no longer express OspA and upregulate proteins that have been associated with host adaptation, such as OspC. These findings suggest that upregulated and/or host-adapted borrelia specific molecules are primarily responsible for the high degree of immunity that results following rabbit infection (36). Several proteins have been identified previously in the murine model as being upregulated during infection, including DbpA (10), OspC (35), and OspE and OspF (44). Proteins identified as uniquely expressed during infection include EppA (11), p35 and p37 (14), the OspE-F homologue p21 (45), the OspF homologues bbk2.1 (3), pG (46), and the proteins encoded on operon 2.9-7lpB (2). Many of these proteins, however, have not shown great potential as protective immunogens in the mouse model as a result of either incomplete or no protection (14, 17) or due to antigenic heterogeneity between strains which does not result in heterologous cross-immunity (9, 19). Similarly, we have found in the rabbit model no correlation between challenge immunity and antibody detected against some of these proteins, including DbpA and OspC (12, 36). However, the finding in this study that rabbit skin infection results in large numbers of structurally intact borrelia, which we have found to be host-adapted (36), provides a rich source for identifying potentially new candidate protective immunogens. Indeed, recent antigenic analysis of extracted infected rabbit skin tissue has revealed several novel and strongly antigenic molecules not detected using cultivated borreliae (J. N. Miller and M. A. Lovett, unpublished data). We are currently studying the role these antigens may play in the clearance of spirochetes during skin infection and the development of protective immunity in the rabbit model of Lyme disease.

ACKNOWLEDGMENTS

This study was supported by NIH grant AI-37312 to J. N. Miller and NIH grant AI-29733 to M. A. Lovett.

We thank Xiao Yang Wu for his expert technical assistance and Jonathan Said and Peter Shintaku for their guidance in the preparation and interpretation of the histopathological sections.

Notes

Editor: D. L. Burns

FOOTNOTES

    • Received 20 December 2000.
    • Returned for modification 1 February 2001.
    • Accepted 2 March 2001.
  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Ackermann R.,
    2. Rehse-Küpper B.,
    3. Gollmer E.,
    4. Schmidt R.
    Chronic neurologic manifestations of erythema migrans borreliosis.Ann. N. Y. Acad. Sci.53919881623
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Akins D. R.,
    2. Bourell K. W.,
    3. Caimano M. J.,
    4. Norgard M. V.,
    5. Radolf J. D.
    A new animal model for studying Lyme disease spirochetes in a mammalian host-adapted state.J. Clin. Investig.101199822402250
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Akins D. R.,
    2. Porcella S. F.,
    3. Popova T. G.,
    4. Shevchenko D.,
    5. Baker S. I.,
    6. Li M.,
    7. Norgard M. V.,
    8. Radolf J. D.
    Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue.Mol. Microbiol.181995507520
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Anguita J.,
    2. Persing D. H.,
    3. Rincon M.,
    4. Barthold S. W.,
    5. Fikrig E.
    Effect of anti-interleukin 12 treatment on murine lyme borreliosis.J. Clin. Investig.97199610281034
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Anguita J.,
    2. Persing D. H.,
    3. Rincon M.,
    4. Barthold S. W.,
    5. Fikrig E.
    Effect of anti-interleukin 12 treatment on murine lyme borreliosis.J. Clin. Investig.97199610281034
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Anguita J.,
    2. Samanta S.,
    3. Barthold S. W.,
    4. Fikrig E.
    Ablation of interleukin-12 exacerbates Lyme arthritis in SCID mice.Infect. Immun.65199743344336
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Barbour A. G.
    Isolation and cultivation of Lyme disease spirochetes.Yale J. Biol. Med.571984521525
    OpenUrlPubMedWeb of Science
  8. 8.↵
    1. Barthold S. W.,
    2. Beck D. S.,
    3. Hansen G. M.,
    4. Terwilliger G. A.,
    5. Moody K. D.
    Lyme borreliosis in selected strains and ages of laboratory mice.J. Infect. Dis.1621990133138
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Bockenstedt L. K.,
    2. Hodzic E.,
    3. Feng S.,
    4. Bourrel K. W.,
    5. de Silva A.,
    6. Montgomery R. R.,
    7. Fikrig E.,
    8. Radolf J. D.,
    9. Barthold S. W.
    Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice.Infect. Immun.65199746614667
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Cassatt D. R.,
    2. Patel N. K.,
    3. Ulbrandt N. D.,
    4. Hanson M. S.
    DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies.Infect. Immun.66199853795387
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Champion C. I.,
    2. Blanco D. R.,
    3. Skare J. T.,
    4. Haake D. A.,
    5. Giladi M.,
    6. Foley D.,
    7. Miller J. N.,
    8. Lovett M. A.
    A 9.0-kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection.Infect. Immun.62199426532661
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Chong-Cerrillo C.,
    2. Wu X.-Y.,
    3. Wang Y.-P.,
    4. Blanco D. R.,
    5. Lovett M. A.,
    6. Miller J. N.
    Immune serum from rabbits infected with Borrelia burgdorferi B31 confers complete passive protection against homologous challenge.J. Spiro. Tick-Borne Dis.7200039
    OpenUrl
  13. 13.↵
    1. Duray P. H.
    Histopathology of clinical phases of human Lyme disease.Rheum. Dis. Clin. N. Am.151989691710
    OpenUrlPubMed
  14. 14.↵
    1. Fikrig E.,
    2. Barthold S. W.,
    3. Sun W.,
    4. Feng W.,
    5. Telford S. R. III,
    6. Flavell R. A.
    Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity.Immunity61997531539
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Foley D. M.,
    2. Gayek R. J.,
    3. Skare J. T.,
    4. Wagar E. A.,
    5. Champion C. I.,
    6. Blanco D. R.,
    7. Lovett M. A.,
    8. Miller J. N.
    Rabbit model of Lyme borreliosis: erythema migrans, infection-derived immunity, and identification of Borrelia burgdorferi proteins associated with virulence and protective immunity.J. Clin. Investig.961995965975
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Garcia-Monco J. C.,
    2. Benach J. L.
    The pathogenesis of Lyme disease.Rheum. Dis. Clin. N. Am.151989711726
    OpenUrlPubMedWeb of Science
  17. 17.↵
    1. Hagman K. E.,
    2. Yang X.,
    3. Wikel S. K.,
    4. Schoeler G. B.,
    5. Caimano M. J.,
    6. Radolf J. D.,
    7. Norgard M. V.
    Decorin-binding protein A (DbpA) of Borrelia burgdorferi is not protective when immunized mice are challenged via tick infestation and correlates with the lack of DbpA expression by B. burgdorferi in ticks.Infect. Immun.68200047594764
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Hejka A.,
    2. Schmitz J. L.,
    3. England D. M.,
    4. Callister S. M.,
    5. Schell R. F.
    Histopathology of Lyme arthritis in LSH hamsters.Am. J. Pathol.134198911131123
    OpenUrlPubMedWeb of Science
  19. 19.↵
    1. Jauris-Heipke S.,
    2. Fuchs R.,
    3. Motz M.,
    4. Preac-Mursic V.,
    5. Schwab E.,
    6. Soutschek E.,
    7. Will G.,
    8. Wilske B.
    Genetic heterogenity of the genes coding for the outer surface protein C (OspC) and the flagellin of Borrelia burgdorferi.Med. Microbiol. Immunol.18219933750
    OpenUrlPubMed
  20. 20.↵
    1. Kang I.,
    2. Barthold S. W.,
    3. Persing D. H.,
    4. Bockenstedt L. K.
    T-helper-cell cytokines in the early evolution of murine Lyme arthritis.Infect. Immun.65199731073111
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Keane-Myers A.,
    2. Maliszewski C. R.,
    3. Finkelman F. D.,
    4. Nickell S. P.
    Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice.J. Immunol.156199624882494
    OpenUrlAbstract
  22. 22.↵
    1. Keane-Myers A.,
    2. Nickell S. P.
    Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice.J. Immunol.155199520202028
    OpenUrlAbstract
  23. 23.↵
    1. Keane-Myers A.,
    2. Nickell S. P.
    T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice.J. Immunol.154199517701776
    OpenUrlAbstract
  24. 24.↵
    1. Logigian E. L.,
    2. Kaplan R. F.,
    3. Steere A. C.
    Chronic neurologic manifestations of Lyme disease.N. Engl. J. Med.323199014381444
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Matyniak J. E.,
    2. Reiner S. L.
    T helper phenotype and genetic susceptibility in experimental Lyme disease.J. Exp. Med.181199512511254
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Mbow M. L.,
    2. Zeidner N.,
    3. Panella N.,
    4. Titus R. G.,
    5. Piesman J.
    Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes.Infect. Immun.65199733863390
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Moody K. D.,
    2. Barthold S. W.,
    3. Terwilliger G. A.,
    4. Beck D. S.,
    5. Hansen G. M.,
    6. Jacoby R. O.
    Experimental chronic Lyme borreliosis in Lewis rats.Am. J. Trop. Med. Hyg.421990165174
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    Morbidity and Mortality Weekly Report Lyme disease—United States, 1996.Morbid. Mortal. Wkly. Rep.461997531535
    OpenUrlPubMed
  29. 29.↵
    1. Pachner A. R.,
    2. Duray P.,
    3. Steere A. C.
    Central nervous system manifestations of Lyme disease.Arch. Neurol.461989790795
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Pachner A. R.,
    2. Steere A. C.
    The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis.Neurology3519854753
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Philipp M. T.,
    2. Aydintug M. K.,
    3. Bohm R. P. Jr.,
    4. Cogswell F. B.,
    5. Dennis V. A.,
    6. Lanners H. N.,
    7. Lowrie R. C. Jr.,
    8. Roberts E. D.,
    9. Conway M. D.,
    10. Karaçorlu M.,
    11. Karacorlu M,
    12. Peyman G. A.,
    13. Gubler D. J.,
    14. Johnson B. J. B.,
    15. Piesman J.,
    16. Gu Y.
    Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans.Infect. Immun.61199330473059
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Preac Mursic V.,
    2. Patsouris E.,
    3. Wilske B.,
    4. Reinhardt S.,
    5. Gross B.,
    6. Mehraein P.
    Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease.Infection181990332341
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Pride M. W.,
    2. Brown E. L.,
    3. Stephens L. C.,
    4. Killion J. J.,
    5. Norris S. J.,
    6. Kripke M. L.
    Specific Th1 cell lines that confer protective immunity against experimental Borrelia burgdorferi infection in mice.J. Leukoc. Biol.631998542549
    OpenUrlPubMed
  34. 34.↵
    1. Schmidli J.,
    2. Hunziker T.,
    3. Moesli P.,
    4. Schaad U. B.
    Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis.J. Infect. Dis.1581988905906
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Schwan T. G.,
    2. Piesman J.,
    3. Golde W. T.,
    4. Dolan M. C.,
    5. Rosa P. A.
    Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.Proc. Natl. Acad. Sci. USA92199529092913
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Shang E. S.,
    2. Champion C. I.,
    3. Wu X. Y.,
    4. Skare J. T.,
    5. Blanco D. R.,
    6. Miller J. N.,
    7. Lovett M. A.
    Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.Infect. Immun.68200041894199
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Sonnesyn S. W.,
    2. Manivel J. C.,
    3. Johnson R. C.,
    4. Goodman J. L.
    A guinea pig model for Lyme disease.Infect. Immun.61199347774784
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Stanek G.,
    2. Klein J.,
    3. Bittner R.,
    4. Glogar D.
    Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy.N. Engl. J. Med.3221990249252
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    1. Steere A. C.
    Lyme disease.N. Engl. J. Med.3211989586596
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    1. Steere A. C.,
    2. Batsford W. P.,
    3. Weinberg M.,
    4. Alexander J.,
    5. Berger H. J.,
    6. Wolfson S.,
    7. Malawista S. E.
    Lyme carditis: cardiac abnormalities of Lyme disease.Ann. Intern. Med.931980816
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    1. Steere A. C.,
    2. Grodzicki R. L.,
    3. Kornblatt A. N.,
    4. Craft J. E.,
    5. Barbour A. G.,
    6. Burgdorfer W.,
    7. Schmid G. P.,
    8. Johnson E.,
    9. Malawista S. E.
    The spirochetal etiology of Lyme disease.N. Engl. J. Med.3081983733740
    OpenUrlCrossRefPubMedWeb of Science
  42. 42.↵
    1. Steere A. C.,
    2. Malawista S. E.,
    3. Hardin J. A.,
    4. Ruddy S.,
    5. Askenase W.,
    6. Andiman W. A.
    Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum.Ann. Intern. Med.861977685698
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    1. Steere A. C.,
    2. Schoen R. T.,
    3. Taylor E.
    The clinical evolution of Lyme arthritis.Ann. Intern. Med.1071987725731
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    1. Stevenson B.,
    2. Schwan T. G.,
    3. Rosa P. A.
    Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi.Infect. Immun.63199545354539
    OpenUrlAbstract/FREE Full Text
  45. 45.↵
    1. Suk K.,
    2. Das S.,
    3. Sun W.,
    4. Jwang B.,
    5. Barthold S. W.,
    6. Flavell R. A.,
    7. Fikrig E.
    Borrelia burgdorferi genes selectively expressed in the infected host.Proc. Natl. Acad. Sci. USA92199542694273
    OpenUrlAbstract/FREE Full Text
  46. 46.↵
    1. Wallich R.,
    2. Brenner C.,
    3. Kramer M. D.,
    4. Simon M. M.
    Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo.Infect. Immun.63199533273335
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    1. Zeidner N.,
    2. Dreitz M.,
    3. Belasco D.,
    4. Fish D.
    Suppression of acute Ixodes scapularis-induced Borrelia burgdorferi infection using tumor necrosis factor-alpha, interleukin-2, and interferon-gamma.J. Infect. Dis.1731996187195
    OpenUrlCrossRefPubMedWeb of Science
  48. 48.↵
    1. Zeidner N.,
    2. Mbow M. L.,
    3. Dolan M.,
    4. Massung R.,
    5. Baca E.,
    6. Piesman J.
    Effects of Ixodes scapularis and Borrelia burgdorferi on modulation of the host immune response: induction of a TH2 cytokine response in Lyme disease-susceptible (C3H/HeJ) mice but not in disease-resistant (BALB/c) mice.Infect. Immun.65199731003106
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Immunohistochemical Analysis of Lyme Disease in the Skin of Naive and Infection-Immune Rabbits following Challenge
Celeste Chong-Cerrillo, Ellen S. Shang, David R. Blanco, Michael A. Lovett, James N. Miller
Infection and Immunity Jun 2001, 69 (6) 4094-4102; DOI: 10.1128/IAI.69.6.4094-4102.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Immunohistochemical Analysis of Lyme Disease in the Skin of Naive and Infection-Immune Rabbits following Challenge
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Immunohistochemical Analysis of Lyme Disease in the Skin of Naive and Infection-Immune Rabbits following Challenge
Celeste Chong-Cerrillo, Ellen S. Shang, David R. Blanco, Michael A. Lovett, James N. Miller
Infection and Immunity Jun 2001, 69 (6) 4094-4102; DOI: 10.1128/IAI.69.6.4094-4102.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • Notes
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Borrelia burgdorferi Group
Erythema Chronicum Migrans
Lyme disease
skin

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522